Niacin Skin Flush Response in Patients With Schizophrenia
Condition:   SchizophreniaIntervention:   Biological: Niacin skin testSponsor:   Isfahan University of Medical SciencesCompleted - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 28, 2015 Category: Research Source Type: clinical trials

Evaluation of the Effects of Niacin Therapy on Lipoprotein Composition and Function
Condition:   Cardiovascular DiseaseIntervention:   Dietary Supplement: Niacin Extended ReleaseSponsor:   National Heart, Lung, and Blood Institute (NHLBI)Not yet recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2014 Category: Research Source Type: clinical trials

Effects of Niacin Therapy on Lipoprotein Composition and Function
Condition:   Cardiovascular DiseaseIntervention:   Dietary Supplement: Niacin Extended ReleaseSponsor:   National Heart, Lung, and Blood Institute (NHLBI)Recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2014 Category: Research Source Type: clinical trials

Niacin on Immune Activation : a Proof-of-concept Study
Condition:   HIVInterventions:   Drug: Niacin;   Drug: NiacinSponsors:   McGill University Health Center;   CIHR Canadian HIV Trials NetworkActive, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 17, 2013 Category: Research Source Type: clinical trials

Benefit of Elevation of HDL-C in Women
Condition:   Cardiovascular OutcomesInterventions:   Drug: NIaspan;   Drug: PlaceboSponsors:   Cedars-Sinai Medical Center;   Cedars-Sinai Medical CenterCompleted - verified August 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2013 Category: Research Source Type: clinical trials

Comparison of TRIA-662 500 mg and Niaspan 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions
Condition:   HealthyInterventions:   Drug: Niaspan;   Drug: TRIA-662Sponsors:   Cortria Corporation;   Cortria Corporation;   PPD;   Pharmena North AmericaCompleted - verified August 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2013 Category: Research Source Type: clinical trials